V ascular endothelial cell apoptosis plays an important role in angiogenesis and vascular remodeling. [1] [2] [3] [4] [5] [6] [7] [8] Disruption of the endothelium in response to stroke, diabetes, ischemia, hypertension, and vascular injury is induced in part through activation of proapoptotic regulatory pathways. [1] [2] [3] [4] [5] [6] [7] Moreover, recent evidence suggests that prevention of endothelial apoptosis may improve angiogenesis and endothelial function. 6, 8 Thus, defining novel genes expressed in the endothelium may lead to a better understanding of the signaling pathways mediating endothelial cell fate under conditions of angiogenesis and vascular remodeling.
Redox factor-1 (Ref-1) (also known as APE, 9 HAP1, 10 and APEX 11 ) is a ubiquitous, multifactorial protein that is a redox-sensitive regulator of multiple transcription factors, including nuclear factor-B (NF-B), c-myc, AP-1, and HIF-1␣ 9 -14 as well as an apurinic/apyrimidinic endonuclease in the base excision repair pathway. The potential importance of Ref-1 gene expression as a critical determinant of cell fate is underscored by the fact that mice lacking a functional Ref-1 gene die during embryonic development, with embryos exhibiting a preponderance of pyknotic cells. 15 In addition, cell lines expressing an antisense Ref-1 transcript exhibit a striking increase in sensitivity to oxidative stress. 16 To our knowledge, the role of Ref-1 as a determinant of endothelial cell fate has not been described.
The endothelium plays a central role in modulating the tissue response to ischemic injury. In the context of ischemic injury, endothelial cell viability may be compromised by hypoxia and the release of cytokines by inflammatory cells. We hypothesized that Ref-1 plays a critical role in the regulation of endothelial cell fate in response to pathophysiological stimuli, such as hypoxia and tumor necrosis factor (TNF). The present study demonstrates that the transient upregulation of Ref-1 significantly inhibits both hypoxia and TNF-mediated endothelial cell apoptosis. Moreover, NF-B activation seems to be a critical yet context-specific down- 
Materials and Methods

Cells
Human umbilical vein endothelial cells (HUVECs) (Clonetics) were grown in endothelial growth media (Clonetics) that contains bovine brain extract (12 g/mL), FBS (2%), hydrocortisone (1 g/mL), human epidermal growth factor (10 g/mL), gentamicin (100 g/ mL), and amphotericin-B (0.05 g/mL) and used between passages 2 and 5.
Calf pulmonary artery endothelial (CPAE) cells (ATCC) were grown in DMEM, 10% FBS, and 1% penicillin/streptomycin (Gibco, Life Technologies) and used between passages 18 and 26.
Materials
The following materials were used: human recombinant TNF-␣ (Genzyme), BCA protein assay (Biorad), Hoechst 33342 (Molecular Probes) enhanced green fluorescent protein expression vector (pEGFP-C1) (Clontech), Mito tracker red expression vector (pDsRed1-Mito) (Clontech), pCB6-Ref-1 (kind gift from T. Curran, St. Jude Children's Research Hospital, Memphis, Tenn), IB dominant-negative expression vector (S32A/S36A) (Upstate Biotechnology), pcDNA3.1 expression vector (Invitrogen), a previously described Ref-1 deletion mutant that abolishes all redox activity, 17 pNF-B-luciferase vector and thymidine-kinase-luciferase vector (negative control) (Clontech), Effectene (Qiagen), luciferase activity assay (Promega), endothelial basal medium, endothelial growth media, bovine brain extract (Clonetics), protease inhibitor cocktail (Roche Molecular Biochemicals), anti-Ref-1 (Santa Cruz Technologies), goat anti-rabbit HRP-linked secondary antibodies (Transduction Labs), vimentin monoclonal antibody (Sigma), chemiluminescent detection reagent (Amersham Pharmacia Biotech) caspase 3 cleavage activity assay (Biovision), and DEVD caspase 3 peptide blocker (DEVD-FMK) (Biovision).
Transfection
All transfections were carried out in CPAE cells using a lipid-based transfection strategy (Effectene). Transfection efficiency was Ϸ25% to 30%. The previously described Ref-1 deletion mutant lacking the N-terminal 116 amino acids that abolishes all redox activity 17 was constructed by amplifying 591 bp of Ref-1 with the following primers: 5Ј-GTAAAGCTTATGGATCAATACTGGTCAGCTCCTTCGG-3Ј and 5Ј-GTAGAATTCTTACAGTGCTAGGTATAGGGTGATAGG-3Ј. The product was digested with HindIII and EcoRI, sequence verified, and cloned into pcDNA3.1.
CPAE cells were cotransfected with Effectene in the presence of growth media with one of the following expression vectors: pDsRed1-Mito or pEGFP-C1 (fluorescent markers) and pcDNA3.1 (control), pCB6-Ref-1, or a previously described Ref-1 deletion mutant. 17 A subset of experiments involved cotransfection of pCB6-Ref-1 or the control expression vector (pcDNA3.1) with an IB (S32A/S36A) dominant-negative expression vector. 18 Twenty-four hours after transfection, CPAE cells were exposed to hypoxic (2% oxygen) or normoxic (21% oxygen) conditions while in the presence of growth media (DMEMϩ10% FBS) for 24 hours. Alternatively, CPAE cells were treated with human TNF in DMEM under normoxic conditions for 24 hours. Apoptotic nuclei were assessed with Hoechst 33342 staining in the transfected (pDsRed1-Mito or pEGFP-C1) population as previously described. 19 Initial experiments confirmed that transfection with a control vector containing the herpes simplex virus thymidine kinase promoter along with luciferase in the absence of the enhancer elements had no significant effect on luciferase activity.
NF-B Activity
Western Blotting
CPAE cells and HUVECs were lysed with RIPA buffer (containing, in mmol/L, NaCl 150, Tris 10, EDTA 1, and PMSF 1 and 1% Triton X-100 and 1% deoxycholic acid) containing a protease-inhibitor cocktail, centrifuged, and assayed for total protein. Equal amounts of cell lysates were loaded on 12% SDS gels, transferred to nitrocellulose membranes, and probed as previously described. 19 As an additional control, blots were reprobed with vimentin to confirm equal loading as well as to verify that the decrease in Ref-1 protein expression was not attributable to an overall decrease in protein synthesis. Finally, all membranes were stained with Ponceau Red to reverify equal protein loading and equal transfer of all protein to the membrane.
Apoptosis
Both CPAE cells and HUVECs were grown on 6-well plates to near confluence for all apoptosis experiments. For the hypoxia experiments, CPAE cells were placed in DMEM plus 10% FBS and HUVECs were placed in endothelial basal media supplemented with bovine brain extract. These media conditions were chosen to minimize basal apoptosis. Both CPAE cells and HUVECs were then placed in an incubator containing 2% oxygen (hypoxia) or 21% oxygen (normoxia) for 24 hours.
It is noted that a separate series of experiments were completed in which HUVECs were also placed in DMEM plus 10% FBS (similar to CPAE cells) and subjected to hypoxia (data not shown). Results were similar under both media conditions.
For TNF-induced experiments, CPAE cells were placed in DMEM in the absence of FBS and HUVECs in endothelial basal media supplemented with bovine brain extract and treated with TNF or PBS for 24 hours. Apoptosis was assessed by staining with the nuclear chromatin dye H33342 and quantitating the percentage of apoptotic nuclei in each sample (400 cells counted per sample). As an additional assay of apoptotic cell death, caspase 3 activity was assessed using a fluorometric caspase 3 cleavage activity assay according to the manufacturer's directions. 19 Caspase 3 cleavage activity is expressed as a normalized ratio of arbitrary fluorophore units inhibitable by DEVD-FMK in treated cells divided by caspase activity in untreated cells. Our laboratory has performed extensive validations of these assays in vivo and in vitro with other techniques for assessing apoptosis. 19 -21 
Statistics
Comparisons between two groups were analyzed via Student's t test (PϽ0.05), and comparisons between three groups were analyzed by ANOVA with a Student-Newman-Keuls posthoc test (PϽ0.05). n indicates the total number of replicates in multiple experiments. Data are presented as meanϮSE. The hypoxia-induced decrease in Ref-1 protein expression was followed by a significant induction of apoptosis in CPAE cells and HUVECs at 24 hours as measured by assessing nuclear chromatin morphology and determining caspase 3 activity. In CPAE cells, hypoxia resulted in a significant increase in the percentage of apoptotic nuclei (normoxia, 5Ϯ1%; hypoxia, 15Ϯ1%; nϭ6, PϽ0.001). In accord with the significant increase in the condensed and coalesced nuclei, caspase 3 activity was significantly upregulated in CPAE cells after hypoxia (normoxia, 1.00Ϯ0.01 normalized ratio of arbitrary fluorophore units inhibitable by the DEVD caspase 3 blocker DEVD-FMK; hypoxia, 1.60Ϯ0.02; nϭ12, PϽ0.001). HUVECs also underwent apoptosis in response to hypoxia as measured by caspase 3 activity (normoxia 1.02Ϯ0.02; hypoxia, 1.13Ϯ0.01; nϭ12, PϽ0.001). We saw no significant change in the percentage of apoptotic nuclei at 
Results
Hypoxic
Cytokine Injury: Modulations of Endothelial Cell Fate
To determine if Ref-1 was able to promote endothelial cell survival in response to other pathobiological stimuli present in the context of ischemic injury, we exposed HUVECs and CPAE cells to human TNF for 24 hours. TNF induced a dose-dependent apoptotic response in HUVECs as measured by H33342 (Figure 4) . TNF induced a similar dose-dependent effect in CPAE cells (vehicle, 7Ϯ1%; 0.25 ng/mL TNF, 16Ϯ1%; 0.4 ng/mL TNF, 18Ϯ2%; 1 ng/mL TNF, 23Ϯ1%; 40 ng/mL TNF, 27Ϯ1%; nϭ10, PϽ0.001). As another means of confirming the apoptotic response, we measured caspase 3 activity. Indeed, caspase 3 activity was significantly enhanced in CPAE cells treated with TNF (control, 1.00Ϯ0.02 versus 1.32Ϯ0.01; nϭ5, PϽ0.001).
Ref (Figure 8) . Thus, the data suggest that the ability of Ref-1 to inhibit apoptosis is attributable in part to its role in potentiating the activation of NF-B.
Discussion
Increasing evidence points to a role for apoptotic regulatory pathways as critical determinants in the progression of angiogenesis and vascular remodeling. Moreover, prevention of endothelial apoptosis improves angiogenesis after ischemia and preserves endothelial dysfunction in disease states such as diabetes. 6 -8 We have demonstrated a critical antiapo- Ref-1 is a multifactorial protein involved in both DNA repair as well as redox-mediated transcriptional events, including the activation of transcription factors NF-B, AP-1, c-myb, and members of the ATF/CREB family. 12, 13, 17 The N-terminal 116 amino acid domain, partially absent in its bacterial homolog exonuclease III, has been shown to be responsible for its redox regulation, whereas the C-terminal domain is largely responsible for its DNA repair activity. 17 Several studies have documented that reducing agents, in- though speculative, our data would suggest the likely possibility that this redox deletion mutant acts in a dominantnegative manner. The increased susceptibility of endothelial cells to both TNF-and hypoxia-induced apoptosis after deletion of the redox domain of Ref-1 suggests that endogenous Ref-1 plays a critical protective role in the vasculature.
Hypoxia and TNF have both been shown to induce NF-B activation in endothelial cells. 22-24,28 -30 However, the role of NF-B under these conditions in promoting an antiapoptotic signaling cascade is controversial. 24,28 -31 12, 13, 32 However, the role of AP-1 in regulating endothelial cell fate is not clear. 33, 34 Ref-1 has also been demonstrated to activate p53 and induce apoptosis in human tumor cell lines. 35 Given that we clearly document an antiapoptotic effect of Ref-1 on both TNF-␣ and hypoxia-induced apoptosis, it is unlikely that a proapoptotic effect via p53 is a major component of its effect in endothelial cells.
Inhibition of endothelial apoptosis in response to hypoxia may have several therapeutic advantages. Indeed, the regulation of a family of hypoxia-inducible factors (HIFs) that bind specifically to promoters and enhancers in genes important in adaptation to hypoxia, such as critical glycolytic enzymes, glucose transporters, and vascular endothelial growth factor, seems to play an important role in promoting endothelial cell survival. 36 37, 40 However, the influence of HIF-1␣ on cell fate is cell type-specific and dependent on several factors, including growth factors, cell density, pH, and glucose concentrations. 37 
